Susan L. Uprichard
Affiliations: | Microbiology and Immunology | University of Illinois at Chicago, Chicago, IL, United States |
Area:
Virology Biology, Molecular Biology, Cell BiologyGoogle:
"Susan Uprichard"Children
Sign in to add trainee| Katherine A. Marsh | grad student | 2012 | University of Illinois, Chicago |
| Danyelle N. Martin | grad student | 2012 | University of Illinois, Chicago |
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Hailegiorgis A, Ishida Y, Collier N, et al. (2023) Modeling suggests that virion production cycles within individual cells is key to understanding acute hepatitis B virus infection kinetics. Plos Computational Biology. 19: e1011309 |
| Maya S, Hershkovich L, Cardozo-Ojeda EF, et al. (2023) Hepatitis delta virus RNA decline post-inoculation in human NTCP transgenic mice is biphasic. Mbio. e0100823 |
| Maya S, Hershkovich L, Cardozo-Ojeda EF, et al. (2023) Hepatitis delta virus RNA decline post inoculation in human NTCP transgenic mice is biphasic. Biorxiv : the Preprint Server For Biology |
| Shekhtman L, Navasa M, Sansone N, et al. (2021) Modeling hepatitis C virus kinetics during liver transplantation reveals the role of the liver in virus clearance. Elife. 10 |
| Durso-Cain K, Kumberger P, Schälte Y, et al. (2021) HCV Spread Kinetics Reveal Varying Contributions of Transmission Modes to Infection Dynamics. Viruses. 13 |
| Reinharz V, Ishida Y, Tsuge M, et al. (2021) Understanding Hepatitis B Virus Dynamics and the Antiviral Effect of Interferon Alpha Treatment in Humanized Chimeric Mice. Journal of Virology. 95: e0049220 |
| Etzion O, Dahari H, Yardeni D, et al. (2020) Response guided therapy for reducing duration of direct acting antivirals in chronic hepatitis C infected patients: a Pilot study. Scientific Reports. 10: 17820 |
| Gorstein E, Martinello M, Churkin A, et al. (2020) Modeling based response guided therapy in subjects with recent hepatitis C infection. Antiviral Research. 104862 |
| Shekhtman L, Cotler SJ, Hershkovich L, et al. (2020) Modelling hepatitis D virus RNA and HBsAg dynamics during nucleic acid polymer monotherapy suggest rapid turnover of HBsAg. Scientific Reports. 10: 7837 |
| Dasgupta S, Imamura M, Gorstein E, et al. (2020) Modeling-based response-guided therapy for chronic hepatitis C under glecaprevir/pibrentasvir may identify patients for ultra-short treatment duration. The Journal of Infectious Diseases |